{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:45:35Z","timestamp":1778190335761,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12288-017-0876-y","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T06:14:48Z","timestamp":1505801688000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India"],"prefix":"10.1007","volume":"34","author":[{"given":"Pankaj","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday","family":"Yanamandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Khadwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepesh","family":"Lad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun D.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshit","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. U. S.","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"issue":"6","key":"876_CR1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111(6):2962\u20132972","journal-title":"Blood"},{"issue":"4","key":"876_CR2","first-page":"210","volume":"23","author":"L Kumar","year":"2010","unstructured":"Kumar L, Verma R, Radhakrishnan VR (2010) Recent advances in the management of multiple myeloma. Nat Med J India 23(4):210\u2013218","journal-title":"Nat Med J India"},{"issue":"1","key":"876_CR3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.1987.tb06890.x","volume":"66","author":"PJ Selby","year":"1987","unstructured":"Selby PJ, McElwain TJ, Nandi AC, Perren TJ, Powles RL, Tillyer CR et al (1987) Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 66(1):55\u201362","journal-title":"Br J Haematol"},{"issue":"12","key":"876_CR4","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","volume":"95","author":"R Desikan","year":"2000","unstructured":"Desikan R, Barlogie B, Sawyer J, Ayers D, Tricot G, Badros A et al (2000) Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 95(12):4008\u20134010","journal-title":"Blood"},{"issue":"2","key":"876_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau J-L, Stoppa A-M, Sotto J-J, Fuzibet J-G, Rossi J-F et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335(2):91\u201397","journal-title":"N Engl J Med"},{"issue":"19","key":"876_CR6","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(19):1875\u20131883","journal-title":"N Engl J Med"},{"issue":"1","key":"876_CR7","first-page":"7","volume":"95","author":"S Lenhoff","year":"2000","unstructured":"Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL et al (2000) Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60\u00a0years with newly diagnosed multiple myeloma: a population-based study. Blood 95(1):7\u201311","journal-title":"Blood"},{"issue":"2","key":"876_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","volume":"13","author":"J Koreth","year":"2007","unstructured":"Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC et al (2007) High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transpl 13(2):183\u2013196","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"876_CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.md.0000173272.71949.a1","volume":"84","author":"V L\u00e9vy","year":"2005","unstructured":"L\u00e9vy V, Katsahian S, Fermand JP, Mary JY, Chevret S (2005) A meta-analysis on data from 575 patients with multiple myeloma randomly assigned to either high-dose therapy or conventional therapy. Medicine 84(4):250\u2013259","journal-title":"Medicine"},{"issue":"1","key":"876_CR10","doi-asserted-by":"crossref","first-page":"e2014046","DOI":"10.4084\/mjhid.2014.046","volume":"6","author":"SK Sharma","year":"2014","unstructured":"Sharma SK, Choudhary D, Gupta N, Dhamija M, Khandelwal V, Kharya G et al (2014) Cost of hematopoietic stem cell transplantation in India. Mediterr J Hematol Infect Dis 6(1):e2014046","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"876_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bmt.2008.343","volume":"43","author":"L Kumar","year":"2009","unstructured":"Kumar L, Ghosh J, Ganessan P, Gupta A, Hariprasad R, Kochupillai V (2009) High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country. Bone Marrow Transpl 43(6):481\u2013489","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"876_CR12","first-page":"172","volume":"26","author":"UK Nath","year":"2010","unstructured":"Nath UK, Chakrabarti P, Ray SS, Chaudhuri U (2010) Starting autologous transplantation in a non-hepa filtered unit in a medical college with severe resource constraints. Indian J Hematol Blood Transfus 26(4):172","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"8","key":"876_CR13","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328\u2013e346","journal-title":"Lancet Oncol"},{"key":"876_CR14","first-page":"S67","volume":"1","author":"P Ashok","year":"2015","unstructured":"Ashok P, Mani K, Sadashivudu G, Srinivas ML (2015) Study of quality of life in multiple myeloma patients after autologous stem cell transplantation. Indian J Hematol Blood Transf 1:S67\u2013S68","journal-title":"Indian J Hematol Blood Transf"},{"issue":"2","key":"876_CR15","first-page":"61","volume":"13","author":"S Gupta","year":"2000","unstructured":"Gupta S, Kumar L, Raju GM, Kochupillai V, Shukla DK (2000) Autologous bone marrow\/stem cell transplantation: initial experience at a north Indian referral centre. Natl Med J India 13(2):61\u201366","journal-title":"Natl Med J India"},{"key":"876_CR16","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1200\/jco.2009.27.15_suppl.7041","volume":"1","author":"A Gupta","year":"2009","unstructured":"Gupta A, Kumar L, Dabkara D, Gupta D, Sharma O, Sreeniwas V (2009) Multiple myeloma: autologous stem cell transplantation versus conventional chemotherapy\u2014a retrospective age and stage matched analysis. J Clin Oncol 1:7041","journal-title":"J Clin Oncol"},{"issue":"7","key":"876_CR17","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3109\/10428194.2015.1135434","volume":"57","author":"J Lu","year":"2016","unstructured":"Lu J, Hou J, Liu K-Y, Parmar S, De La Fuente A, Andersson B et al (2016) Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th international hematologic malignancies conference: Bridging the Gap 2015, Beijing, China. Leuk Lymphoma 57(7):1534\u20131538","journal-title":"Leuk Lymphoma"},{"key":"876_CR18","unstructured":"Prakash Yadav S, Kalra M, Sachdeva A, Dinand V, Parashar N, Kohli S et al (2009) The experience of hematopoietic stem cell transplantation from an emerging centre in north India. In: Blood conference: 51st annual meeting of the American society of hematology, ASH New Orleans, LA United States Conference Start, vol 114, no. 22"},{"key":"876_CR19","first-page":"S65","volume":"1","author":"TG Sagar","year":"2015","unstructured":"Sagar TG, Rathinam K, Trivadi G, Rejiv R, Prasanth G (2015) Outcomes in multiple myeloma post high dose chemotherapy and autologous stem cell transplantation-single institute experience. Indian J Hematol Blood Transf 1:S65","journal-title":"Indian J Hematol Blood Transf"},{"issue":"11","key":"876_CR20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00277-011-1205-4","volume":"90","author":"L Kumar","year":"2011","unstructured":"Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Katyal S et al (2011) Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India. Ann Hematol 90(11):1317\u20131328","journal-title":"Ann Hematol"},{"issue":"4","key":"876_CR21","first-page":"243","volume":"29","author":"L Kumar","year":"2013","unstructured":"Kumar L (2013) Autologous stem cell transplant for multiple myeloma. Indian J Hematol Blood Transf 29(4):243","journal-title":"Indian J Hematol Blood Transf"},{"key":"876_CR22","first-page":"26","volume":"54","author":"TK Dolai","year":"2013","unstructured":"Dolai TK, Kumar M, Kumar Mandal P, Saha S, Bagchi B, Panigrahi A et al (2013) Auto-SCT for myeloma patients in non-HEPA filtered room: initial experience of a tertiary care center. Leuk Lymphoma 54:26","journal-title":"Leuk Lymphoma"},{"key":"876_CR23","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.clml.2015.07.390","volume":"15","author":"E Kaul","year":"2015","unstructured":"Kaul E, Kothari S, Sharma SK, Dhamija M, Kharya G, Khandelwal V et al (2015) Day 4 peripheral blood stem cell collection in myeloma patients is feasible and cost-effective in a majority of patients. Clin Lymphoma Myeloma Leuk 15:e169\u2013e170","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"876_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clml.2012.08.007","volume":"13","author":"L Kumar","year":"2013","unstructured":"Kumar L, Cyriac SL, Tejomurtula TV, Bahl A, Biswas B, Sahoo RK et al (2013) Autologous stem cell transplantation for multiple myeloma: identification of prognostic factors. Clin Lymphoma Myeloma Leuk 13(1):32\u201341","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"876_CR25","first-page":"710543","volume":"2015","author":"CA Shah","year":"2015","unstructured":"Shah CA, Karanwal A, Desai M, Pandya M, Shah R (2015) Hematopoietic stem-cell transplantation in the developing world: experience from a center in Western India. J Oncol 2015:710543","journal-title":"J Oncol"},{"issue":"21","key":"876_CR26","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood.V124.21.3997.3997","volume":"124","author":"B Bagal","year":"2014","unstructured":"Bagal B, Jain H, Dangi U, Sengar M, Kannan S, Rangarajan V et al (2014) Pretransplant PET positivity predicts early relapse with poor outcome in patients of multiple myeloma undergoing autologous stem cell transplantation. Blood 124(21):3997","journal-title":"Blood"},{"issue":"4","key":"876_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/0971-5851.107078","volume":"33","author":"A Mukhopadhyay","year":"2012","unstructured":"Mukhopadhyay A, Gupta P, Basak J, Chakraborty A, Bhattacharyya D, Mukhopadhyay S et al (2012) Stem cell transplant: an experience from eastern India. Indian J Med Paediatr Oncol 33(4):203\u2013209","journal-title":"Indian J Med Paediatr Oncol"},{"key":"876_CR28","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Bhalla A, Khatri SL, Anand Simar S, Bhargava M, Saran R (2011) Bortezomib plus dexamethasone as induction treatment followed by autologous peripheral blood stem cell transplantation in patients with multiple myeloma: a study from india. In: Blood conference: 53rd annual meeting of the American society of hematology, ASH, vol 118, no. 21","DOI":"10.1182\/blood.V118.21.4584.4584"},{"issue":"15 SUPPL. 1","key":"876_CR29","doi-asserted-by":"crossref","first-page":"e17003","DOI":"10.1200\/jco.2012.30.15_suppl.e17003","volume":"30","author":"BP Bagal","year":"2012","unstructured":"Bagal BP, Khattry N, Dongre A, Kanan S, Menon H, Sengar M et al (2012) Outcomes of autologous stem cell transplant (ASCT) in multiple myeloma from a tertiary cancer center in India. J Clin Oncol Conf 30(15 SUPPL. 1):e17003","journal-title":"J Clin Oncol Conf"},{"issue":"4","key":"876_CR30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cam4.257","volume":"3","author":"L Kumar","year":"2014","unstructured":"Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A et al (2014) Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med 3(4):939\u2013946","journal-title":"Cancer Med"},{"key":"876_CR31","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.clml.2015.07.393","volume":"15","author":"RR Boya","year":"2015","unstructured":"Boya RR, Bakhshi S, Gogia A, Sahoo RK, Kumar L (2015) Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation: a prospective study. Clin Lymphoma Myeloma Leuk 15:e171\u2013e172","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"15 SUPPL. 1","key":"876_CR32","doi-asserted-by":"crossref","first-page":"e18013","DOI":"10.1200\/jco.2015.33.15_suppl.e18013","volume":"33","author":"R Reddy","year":"2015","unstructured":"Reddy R, Bakhshi S, Sharma A, Sahoo R, Gogia A, Malik PS et al (2015) Poor mobilization of peipheral blood stem cells (PBSC) in patients undergoing autologous stem cell transplantation (ASCT): a prospective study. J Clin Oncol Conf 33(15 SUPPL. 1):e18013","journal-title":"J Clin Oncol Conf"},{"issue":"3","key":"876_CR33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000440970","volume":"135","author":"R Munker","year":"2015","unstructured":"Munker R, Shi R, Nair B, Devarakonda S, Cotelingam JD, McLarty J et al (2015) The Shreveport myeloma experience: survival, risk factors and other malignancies in the age of stem cell transplantation. Acta Haematol 135(3):146\u2013155","journal-title":"Acta Haematol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-017-0876-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-017-0876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-017-0876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T21:56:48Z","timestamp":1602971808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-017-0876-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1007\/s12288-017-0876-y","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]}}}